86 related articles for article (PubMed ID: 6457706)
1. High density lipoprotein cholesterol and apolipoprotein A-I levels in 32-33-year-old women on steroid contraceptives-differences between two frequently used low-estrogen pills.
Havekes L; van Gent CM; Stegerhoek CI; Arntzenius AC; Hessel LW
Clin Chim Acta; 1981 Oct; 116(2):223-9. PubMed ID: 6457706
[TBL] [Abstract][Full Text] [Related]
2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
3. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
4. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
5. Serum lipids and lipoproteins during therapeutic amenorrhea induced by lynestrenol and depot-medroxyprogesterone acetate.
Huovinen K; Tikkanen MJ; Autio S; Härkönen T; Lommi L; Varonen S; Wilska ML
Acta Obstet Gynecol Scand; 1991; 70(4-5):349-54. PubMed ID: 1836088
[TBL] [Abstract][Full Text] [Related]
6. [Changes in plasma lipids caused by oral contraceptives].
Kaffarnik H
Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
[No Abstract] [Full Text] [Related]
7. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
8. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
Wynn V; Niththyananthan R
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):766-71. PubMed ID: 6801982
[TBL] [Abstract][Full Text] [Related]
9. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
März W; Gross W; Gahn G; Romberg G; Taubert HD; Kuhl H
Am J Obstet Gynecol; 1985 Oct; 153(3):287-93. PubMed ID: 2931988
[TBL] [Abstract][Full Text] [Related]
10. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose oral contraceptives on lipoproteins and lipolytic enzymes: differences between two commonly used preparations.
Leuven JA; Havekes L; van der Kooij-Pontier HA; Starmans RJ; Jansen H; Bouwhuis-Hoogerwerf ML; de Pagter HA; Hessel LW
Metabolism; 1984 Nov; 33(11):1039-42. PubMed ID: 6493047
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
13. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
Kay CR
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):762-5. PubMed ID: 6801981
[TBL] [Abstract][Full Text] [Related]
14. Blood platelet biochemistry in women receiving steroid contraceptives.
Briggs M
Haematologia (Budap); 1973; 7(3):347-67. PubMed ID: 4790074
[No Abstract] [Full Text] [Related]
15. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
16. Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Miller VT; Muesing RA; LaRosa JC; Stoy DB; Phillips EA; Stillman RJ
Obstet Gynecol; 1991 Feb; 77(2):235-40. PubMed ID: 1846437
[TBL] [Abstract][Full Text] [Related]
17. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
Phillips NR; Havel RJ; Kane JP
Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694
[TBL] [Abstract][Full Text] [Related]
18. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
19. Liver function tests in patients on oral progestogens.
Engineer AD; Gupta V; Tandon P
J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
[TBL] [Abstract][Full Text] [Related]
20. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
